Adjournment debate on Thursday, 8 May 2008, in the House of Commons, led by Kevin Barron. The answering member was Baroness Primarolo.
National Institute for Health and Clinical Excellence
Westminster hall debate on a motion for the adjournment on the National Institute for Health and Clinical Excellence.[Relevant documents: Health Select Committee first report of session 2007-08, HC 27, and the Government's response, Cm 7331.)
Secondary information
- Type
- Parliamentary proceeding
- Reference
- 475 c311-48WH
- Session
- 2007-08
- Department
- Department of Health
- Chamber / Committee
- Westminster Hall
- Related items
-
National Institute for Health and Clinical Excellence. Government response to the Health Select Committee first report of session 2007-08 (HC 27).
Thursday, 6 March 2008
Command papers
House of Commons
- Proceeding contributions
-
Baroness Primarolo | 475 c343-4WH (Link to this contribution) There are two steps in the discussion and several processes are involved. The first is to assess wha...
-
Sandra Gidley | 475 c343WH (Link to this contribution) I welcome the Minister's sentiment, but one of the problems in Hampshire, which the hon. Member for ...
-
Maria Miller | 475 c344WH (Link to this contribution) I was taken aback to be told that the rethink of the IVF policy in Hampshire was going to be conduct...
-
Baroness Primarolo | 475 c344-5WH (Link to this contribution) The hon. Lady is, I believe, referring to the collection of information and to ensuring that PCTs te...
-
Kevin Barron | 475 c345-8WH (Link to this contribution) I shall be brief. I congratulate the Minister on speaking for 35 minutes and not mentioning the R-wo...
-
Kevin Barron | 475 c311-7WH (Link to this contribution) To preface the debate, I thank the secretariat of the Select Committee on Health, whose seven member...
-
Baroness Primarolo | 475 c317WH (Link to this contribution) I am sorry to interrupt my hon. Friend in mid flow, but I think that it would be helpful if I tell h...
-
Kevin Barron | 475 c317WH (Link to this contribution) I am grateful to the Minister for that. I know that if someone is given a strong letter that says th...
-
Maria Miller | 475 c327-8WH (Link to this contribution) The Minister has raised an important point. Presumably, what she as a Minister in the Department of ...
-
Maria Miller | 475 c325-6WH (Link to this contribution) It is with a little caution that I rise to speak after the hon. Members for Dartford (Dr. Stoate) an...
-
Ian Gibson | 475 c326WH (Link to this contribution) First, does the hon. Lady think that fastness is not always associated with accuracy of information,...
-
Maria Miller | 475 c326WH (Link to this contribution) I thank the hon. Gentleman for raising those points. I will discuss the length of time that should b...
-
Baroness Primarolo | 475 c326-7WH (Link to this contribution) The hon. Lady is touching on an important wider point for the health service, and perhaps she will s...
-
Ian Gibson | 475 c322WH (Link to this contribution) Would my hon. Friend include orphan drugs and ultra-orphan drugs in the mystique that he mentions, w...
-
Howard Stoate | 475 c322-4WH (Link to this contribution) I pay tribute to my hon. Friend, who does a huge amount of work for cancer patients and who has quit...
-
Sandra Gidley | 475 c324WH (Link to this contribution) We all like to get hung up on the question of thresholds, but surely the hon. Gentleman saw the evid...
-
Howard Stoate | 475 c324-5WH (Link to this contribution) I accept the hon. Lady's point, which underlines the great difficulty that we had in making some of ...
-
Howard Stoate | 475 c322WH (Link to this contribution) My hon. Friend makes the important point that we are moving in the right direction, but we have a lo...
-
Howard Stoate | 475 c321WH (Link to this contribution) I shall start by paraphrasing Kryten from the TV series ““Red Dwarf””. There are two problems facing...
-
David Drew | 475 c322WH (Link to this contribution) The Committee's Chairman referred to this earlier, but I have taken part in two events organised by ...
-
Ian Gibson | 475 c320WH (Link to this contribution) Appetising. Well paid.
-
Richard Taylor | 475 c320-1WH (Link to this contribution) Oh! I have no information about how much those people get paid. No doubt some of guests in the Publi...
-
Ian Gibson | 475 c320WH (Link to this contribution) Why are there so few in Britain? Is it just not an appetising job?
-
Richard Taylor | 475 c320WH (Link to this contribution) An advertising job?
-
Sandra Gidley | 475 c319WH (Link to this contribution) I am slightly confused by the hon. Gentleman saying that we do not want clinical freedom. I am sure ...
-
Richard Taylor | 475 c319-20WH (Link to this contribution) I am grateful for that helpful comment. I do not want to be misconstrued. I am talking about when it...
-
Ian Gibson | 475 c318-9WH (Link to this contribution) The hon. Gentleman talks about the need to get evidence earlier. Is that because it comes from the l...
-
Richard Taylor | 475 c319WH (Link to this contribution) That is one of the huge difficulties with drugs. Some of their effects—good and bad—are not discover...
-
Richard Taylor | 475 c318WH (Link to this contribution) It is a great privilege to follow our Chairman, who is allowing us to get out some quite strong cond...
-
Howard Stoate | 475 c318WH (Link to this contribution) The hon. Gentleman will appreciate that there is a great difference between time-honoured and eviden...
-
Richard Taylor | 475 c318WH (Link to this contribution) I thank my friend and medical colleague for that. I absolutely accept that, but things should not be...
-
Maria Miller | 475 c329WH (Link to this contribution) I thank the Minister for that. I am sure that what she has said is right, but when UK pharmaceutical...
-
Baroness Primarolo | 475 c329WH (Link to this contribution) I was at the annual dinner of the Association of the British Pharmaceutical Industry only last week....
-
Kevin Barron | 475 c332WH (Link to this contribution) When we took evidence from the would-be chair of the CQC in this morning's public session, we heard ...
-
Sandra Gidley | 475 c329-32WH (Link to this contribution) It is fair to point out in my opening remarks that the Committee has looked at the National Institut...
-
Sandra Gidley | 475 c332WH (Link to this contribution) Yes, but the matter is not being dealt with at the moment. The CQC will have enough problems trying ...
-
Mark Simmonds | 475 c332-4WH (Link to this contribution) First, may I say what a pleasure it is to have you in the Chair, Mr. Gale? I thank hon. Members, the...
-
Sandra Gidley | 475 c334WH (Link to this contribution) I agree wholeheartedly with the hon. Gentleman, but does he agree that one aspect of the inconsisten...
-
Mark Simmonds | 475 c334-7WH (Link to this contribution) I agree with the first part of the hon. Lady's intervention that this is an extremely important matt...
-
Sandra Gidley | 475 c337WH (Link to this contribution) I apologise to the hon. Gentleman for giving the impression that the appraisal committee was dominat...
-
Baroness Primarolo | 475 c339WH (Link to this contribution) If the hon. Lady will let me reassure her on one further point, I will happily give way. The basis f...
-
Maria Miller | 475 c339WH (Link to this contribution) Will the Minister give way?
-
Baroness Primarolo | 475 c338-9WH (Link to this contribution) This has been an interesting and thoughtful debate, and I congratulate my right hon. Friend the Memb...
-
Baroness Primarolo | 475 c339WH (Link to this contribution) I agree that a constructive, productive working relationship with the pharmaceutical industry is vit...
-
Maria Miller | 475 c339WH (Link to this contribution) I completely endorse the Minister's remarks about value for money. Does she share my concern that th...
-
Mark Simmonds | 475 c337-8WH (Link to this contribution) I am grateful to the hon. Lady for clarifying that. The final point I shall make is about the implem...
-
Baroness Primarolo | 475 c340WH (Link to this contribution) I will give way to the hon. Lady and come back to the hon. Gentleman.
-
Baroness Primarolo | 475 c340WH (Link to this contribution) I do not agree with the one-sided view that the hon. Gentleman is giving with regard to the negotiat...
-
Mark Simmonds | 475 c340WH (Link to this contribution) I am grateful to the Minister for giving way. I just want to clarify a point that she has raised. Of...
-
Baroness Primarolo | 475 c340-3WH (Link to this contribution) Thank you, Mr. Gale. The Select Committee has raised these issues with me, and some of its recommend...
-
Speaker | 475 c340WH (Link to this contribution) Order. I have allowed the debate to continue because the future of the PPRS is clearly an important ...
-
Baroness Primarolo | 475 c340WH (Link to this contribution) On the first point, the agreement was between the Government and the industry. The points with regar...
-
Sandra Gidley | 475 c340WH (Link to this contribution) I have two quick questions. First, with the PPRS, am I correct in thinking that either side can ask ...
- Subjects
- Costs Health services Drugs NHS Medical treatments National Institute for Health and Care Excellence Research
- Link
- View this Parliamentary proceeding on www.publications.parliament.uk
Show all contributions (53)
Librarians' tools
- Timestamp
- 2023-12-05 19:29:09 +0000
- URI
- http://data.parliament.uk/pimsdata/hansard/PROCEEDING_70276
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/hansard/PROCEEDING_70276
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/hansard/PROCEEDING_70276